Hem › Migrän › District of Columbia
Kliniska studier för Migrän i District of Columbia
5 studier för Migrän söker deltagare vid platser i District of Columbia.
Städer i District of Columbia
Officiell studietext (engelska)
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Velocity Clinical Research, Washington DC, Washington D.C.
RekryterarFas 1
Ålder 6 till 11 · Alla kön · Uppdaterad 28 sep. 2026 · NCT06995729Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Velocity Clinical Research, Washington DC, Washington D.C.
RekryterarFas 3
Ålder 6 till 17 · Alla kön · Uppdaterad 28 sep. 2026 · NCT05156398Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Children's National Medical Center, Washington D.C.
RekryterarFas 3
Ålder 6 till 17 · Alla kön · Uppdaterad 24 sep. 2026 · NCT04649242Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Children's National Medical Center, Washington D.C.
RekryterarFas 3
Ålder 6 till 17 · Alla kön · Uppdaterad 24 sep. 2026 · NCT04743141Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Emerson Clinical Research Institute - Connecticut Avenue - Washington /ID# 231693, Washington D.C.
RekryterarFas 3
Ålder 6 till 17 · Alla kön · Uppdaterad 14 sep. 2026 · NCT05125302Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.